For vaccination of healthy horses 6 months of age or older, as an aid in the prevention of abortion and respiratory disease caused by EHV-1 infection.
- An inactivated, purified, concentrated, adjuvanted, tissue culture origin, equine herpesvirus EHV-1 vaccine
- Exceptional safety profile with the smooth Havlogen adjuvant
- Advanced filtration process through the Antigen Purification System (APS™)
For vaccination of healthy horses 6 months of age or older, as an aid in the prevention of abortion and respiratory disease caused by equine herpesvirus type 1 (EHV-1) infection.
Administration and Dosage
For pregnant mares administer a 2 mL dose intramuscularly in the 5th, 7th and 9th months of pregnancy. Three doses are essential for primary immunization. Maiden and barren mares housed or pastured with pregnant mares should be vaccinated on the same schedule. For primary vaccination against respiratory disease administer three 2 mL doses intramuscularly at four to six week intervals. A 2 mL booster dose should be administered annually and at any time epidemic conditions exist or are reported and exposure is imminent.
Store at 2°-7°C (35°-45°F). Shake well before using. Use entire contents when first opened. Do not vaccinate within 21 days before slaughter. Local reaction may occur if this product is given subcutaneously. Inject deep into the muscle only. Anaphylactic reactions may occur. If allergic reaction occurs, treat with epinephrine. Care should be used to avoid injecting your own fingers, hands, or other body parts. Accidental injection can cause serious local reactions. Contact a physician immediately if an accidental injection occurs.
10 x 2 mL (1 dose) sterile syringes per box, individually printed plastic bag with needle
20 mL (10 doses) vial
For additional information, please see the product label.